Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination

Table 3 pARD with a relapse of ARD after infection and after vaccination with JADAS10 where applicable

Patient number	Diagnosis	Severity of relapse	JADAS10 (before)	JADAS10 (after)
Group 1 (after infection)
1	JIA^a	Mild^c	0	3
2^g	JIA	Mild	1	1
3	JIA	Mild	0	4
4	Sjögren’s syndrome	Mild	N/A^f	N/A
5	JIA	Moderate^d	3	5
6	JIA	Moderate	8	10
7	JIA	Moderate	3	19
8	JIA	Moderate	N/A	N/A
9	Chronic idiopathic uveitis	Moderate	N/A	N/A
10	sJIA^b	Severe^e	N/A	N/A
Group 2 (after vaccination)
11	JIA	Mild	1	8
12	JIA	Mild	0	6
13	JIA	Moderate	6	18

^a JIA – juvenile idiopathic arthritis, ^b sJIA – systemic juvenile idiopathic arthritis, ^c Mild relapse – no treatment adjustment was required, ^d Moderate relapse – required a treatment adjustment, ^e Severe relapse – required a treatment adjustment in the hospital (hospitalization), ^f N/A – not applicable, ^g Patient had a transient worsening by description of the parents, on examination JADAS10 before and after was the same (problems subsided before we saw the patient for a check-up)

ISSN: 1546-0096